Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by PoorOpinionon Oct 18, 2018 12:36pm
82 Views
Post# 28828131

RE:RE:Communication idea for Thera

RE:RE:Communication idea for Thera
palinc2000 wrote: In the couple of weeks preceding the Bought Deal on the  55 million US $ Notes Luc/Philippe wre either dangling the 500 Million Sales ,iand or becoming the largest pharma in Canada or working towards the next Billion dollars in market caps  and it worked .

I dont think any communication from Luc would change anything at this stage other than Real positive news 




But surely what you know about the launch and first six month has been positive news? I probably held on to a "fail" scenario for Trogarzo longer than most people here. I think what they've achieved so far rules out that for me now. It's just a question of where the graph goes from here as we add each new data point, thats not fully clear, management arent helping to make that fully clear with clear guidance but some scenarios (like failure) can probably be ruled out. And a few more data points are going to further narrow the likely outcomes.

There's a curious thing I've noticed in finance, they dont seem to like margins of error in their future predictions. The like one number for future projections and then its a question of beat or miss. If I was going to predict future US Torgarzo peak sales I might say $200mil +/- $100mil but in finance it seems you have to give a single target number. Its just possible that given the uncertainty of the future sales curve Luc does have any certainty about a single future number. Coming from a science where a single number is often meaningless unless it includes a measurement of margin of error it seems strange how finance seems to ignore it.
Bullboard Posts